Abbott Laboratories (ABT)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $186.10B
Last updated: Nov 17, 2026 at 4:42 PM ET
Abbott Laboratories (ABT) Stock Chart
Abbott Laboratories (ABT) has a latest price of $104.76 on Nov 17, 2026, 18.3% below its 52-week high of $128.30. Its price fell 19.4% over the past 12 months. The month-end price rose 170.6% over the 10 years through Oct 2026, a compound annual rate of 10.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $140.74 in Dec 2021 and its lowest $38.07 in Nov 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ABT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ABT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 7.9%, and over 6 months it rose 18.8%. The month-end price rose 12.3% over the 3 years through Oct 2026, a compound annual rate of 3.9%.
| Period | Change |
|---|---|
| 1 month | +0.7% |
| 3 months | -7.9% |
| 6 months | +18.8% |
| 12 months | -19.4% |
| 12 months, with dividends | -17.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +12.3% | +3.9% |
| 5 years | -17.6% | -3.8% |
| 10 years | +170.6% | +10.5% |
Price by Year
Its best calendar year was 2017, when the price rose 48.6%, and its weakest was 2022, when it fell 22.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $106.20 | -15.2% |
| 2025 | $125.29 | +10.8% |
| 2024 | $113.11 | +2.8% |
| 2023 | $110.07 | +0.3% |
| 2022 | $109.79 | -22.0% |
| 2021 | $140.74 | +28.5% |
| 2020 | $109.49 | +26.1% |
| 2019 | $86.86 | +20.1% |
| 2018 | $72.33 | +26.7% |
| 2017 | $57.07 | +48.6% |
Trading Range
The price is 1.2% above its 50-day average of $103.56 and 4.0% above its 200-day average of $100.73.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $104.76 | |
| 52-week high | $128.30 | -18.3% |
| 52-week low | $80.89 | +29.5% |
| 50-day average | $103.56 | +1.2% |
| 200-day average | $100.73 | +4.0% |
Price Risk
Over 3 years, its largest fall from a peak was 40.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.10 |
| Largest fall, 1 year | -36.6% |
| Largest fall, 3 years | -40.7% |
Valuation
Abbott Laboratories traded at 24.3x earnings at the end of 2025, against a 5-year median of 23.7x and a 10-year median of 24.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ABT
What is ABT's 1-year price change?
Abbott Laboratories's price fell 19.4% over the past 12 months. With dividends included, the 12-month total return was -17.4%.
What is ABT's 5-year price change?
Abbott Laboratories's month-end price fell 17.6% over the 5 years through Oct 2026, a compound annual decline of 3.8%. These figures leave out dividends.
What is ABT's 52-week high and low?
Abbott Laboratories's 52-week high is $128.30 and its 52-week low is $80.89. Its latest price of $104.76 on Nov 17, 2026 is 18.3% below the high.
What is ABT's beta?
Abbott Laboratories's 1-year beta against the S&P 500 is 0.10, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 36.6%.
Is the ABT chart free?
Yes. Advanced Charting for ABT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ABT pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts